Allux Medical Inc., a developer of minimally-invasive devices for the treatment of upper airway and dermatological inflammatory diseases, is being managed by turnaround/shutdown firm Sherwood Partners, according to its website. VentureWire first reported the news. Allux Medical has raised around $12.2 million in VC funding since 2004, from firms like Prospect Venture Partners, Three Arch Partners and Venrock. www.alluxmedical.com